U.S. federal trademark · Serial No. 86692989 · Reg. No. 5066881
Diagnostic test kits for research and medical use in connection with the detection and characterization of gene expression and mutations associated with cancer through the genomic analysis of rare blood cells, namely, specimen collection tubes, blood sample stabilizing reagents, containers for collecting patient blood and plasma specimens, test forms, packaging and mailing materials, and user information inserts
Providing medical testing and analysis services and information in the field of cancer research and disease classification through the genomic analysis of rare blood cells, namely, providing clinical and medical laboratory tests that detect gene expression and mutations associated with cancer, the evaluation of such tests, and information in the fields of cancer screening, diagnosis and treatment, all for diagnostic or treatment purposes
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.